Study of WM-A1-3389 in Participants With Advanced or Metastatic Solid Tumors and Non-Small Cell Lung Cancer

Conditions:   Advanced Solid Tumor;   Metastatic Solid Tumor;   Lung Cancer;   Colorectal Cancer;   Pancreatic Cancer;   Cholangiocarcinoma;   Head and Neck Cancer;   Non Small Cell Lung Cancer Interventions:   Biological: WM-A1-3389;   Biological: Pembrolizumab Sponsors:   Wellmarker Bio;   Merck Sharp & Dohme LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials